Hints and tips:
Related Special Reports
...Although AstraZeneca is in the race for a treatment, it is far behind the sector’s leaders Eli Lilly and Novo Nordisk....
...Skovronsky said Lilly’s commitment to R&D and its focus on areas of long-term internal expertise have been critical for its success....
...Novo’s next generation drug CagriSema is biopharma’s most valuable R&D project, with a net present value of $30bn, according to Evaluate....
...He argued that the size of an R&D budget was not an automatic guarantee of success. “Two of the companies that had the lowest R&D spending a decade ago were Eli Lilly and Novo Nordisk....
...In between, Ditum investigates the collective acceptance of atrocious pop-culture moments: the media’s preoccupation with Spears’s virginity; R Kelly’s lyrics about his R&B prodigy Aaliyah, who was 12 when...
...Eli Lilly inked a $250mn deal with Shenzhen-based Xtalpi in May. In July, Nvidia invested $50mn in US-based Recursion. Using AI does not guarantee success....
...Q4, Ford Q4, H&R Block Q2, Gartner Q4, Infineon Technologies Q1, Linde Q4, Mitsubishi Q3, Nintendo Q3, Omnicom Q4, Prudential Financial Q4, Snap Q4, Spotify Q4, Toyota Q3, UBS Q4, Virgin Money UK Q1 trading...
...China’s pharma researchers do a lot of R&D of their own, but do not seem to produce many blockbusters....
...Schwartz has named lieutenants and hired confidants from his decades at Goldman Sachs, including new investor relations head Jeff Nedelman and Lindsay LoBue, who will focus on strategic initiatives....
...The UK’s share of global pharma R&D has dropped sharply since 2012, from 7.7 per cent to 4.2 per cent in 2020....
...Critics have also slammed industry leaders Eli Lilly and Biogen for charging excessive prices for treatments for common diseases such as diabetes and Alzheimer’s....
...Eli Lilly last year scrapped development of a drug targeting blood cancers. Bristol Myers Squibb has warned of similar moves....
...Ireland-based life science companies have tripled R&D spending, as they undertake higher value activities including manufacturing of complex biologic medicines....
...Hopes are high for Eli Lilly’s new obesity drug Mounjaro. Like a similar drug from Novo Nordisk, it targets a brain area that regulates appetite....
...But a recent report for a European trade body found pharmaceutical R&D spending was growing faster in the US and China; Europe’s share of global R&D investment, clinical trials and manufacturing output are...
...“Pfizer is very good at selling but historically not renowned as having the R&D engine of a Merck or Lilly....
...“The odds that we wake up and see a J&J or Lilly do something big like buying Alnylam, Incyte or Vertex goes down from where it would have been,” said Stifel’s Opler....
...Meanwhile, our share of the global pharmaceutical R&D market is declining....
...The industry is also worried that R&D productivity is falling....
...US drugmakers AbbVie and Eli Lilly in January became the first pharma companies to pull out of the voluntary scheme with the UK government in protest at the sharp rise in clawback payments....
...Novo Nordisk has followed Eli Lilly in slashing prices for some of its products by 75 per cent....
...It underpins Eli Lilly’s impressive record on innovation. It generated returns on R&D investment of nearly 14 per cent over the five years to 2021, according to Berenberg....
...Lil Jon, Akon, Lindsay Lohan, Ne-Yo, Christina Aguilera, Kim Kardashian, Soulja Boy, Jake Paul, Lil Yachty?...
...by R Can & Sonic Noise. I heard it at a party; it’s a kind of techno dancehall track. It’s so good, so spontaneous....
...Mr Rokos, who is the “R” in the Brevan acronym, generated billions of dollars of trading profit and was paid about $900m during his time at the firm, working closely with Mr Howard....
International Edition